| 3401 |
1924: Increased，Cardiac fibrosis |
1929: Increased incidence of cardiovascular morbidity and mortality |
Nov 20, 2024 |
Nov 20, 2024 |
None
|
| 2948 |
1365: Increase, Apoptosis |
1430: Inhibition of neurotransmitter release |
Jun 20, 2023 |
Jun 20, 2023 |
None
|
| 2852 |
1963: Torsades de Pointes |
351: Increased Mortality |
Jan 29, 2023 |
Jan 29, 2023 |
None
|
| 2853 |
1962: Prolongation of QT interval |
1106: Occurrence, cardiac arrhythmia |
Jan 29, 2023 |
Jan 29, 2023 |
None
|
| 2854 |
1106: Occurrence, cardiac arrhythmia |
1919: Increased，Cardiac dysfunction |
Jan 29, 2023 |
Jan 29, 2023 |
None
|
| 2855 |
1919: Increased，Cardiac dysfunction |
351: Increased Mortality |
Jan 29, 2023 |
Jan 29, 2023 |
None
|
| 2856 |
1635: Increase, DNA strand breaks |
2066: Altered Signaling |
Mar 10, 2023 |
Mar 21, 2023 |
None
|
| 2863 |
1825: Increase, Cell death |
758: Hippocampal Physiology, Altered |
Apr 3, 2023 |
Apr 3, 2023 |
None
|
| 2840 |
2066: Altered Signaling |
2098: Abnormal Neural Remodeling |
Jan 25, 2023 |
Mar 21, 2023 |
None
|
| 2843 |
2066: Altered Signaling |
2089: Altered Bone Cell Homeostasis |
Jan 25, 2023 |
Mar 22, 2023 |
None
|
| 2874 |
2124: increased, Bax |
1825: Increase, Cell death |
Apr 4, 2023 |
Apr 4, 2023 |
None
|
| 2884 |
295: Induction, Upregulation of glucuronyltransferase activity |
2133: Increase, Glucuronidation of T4 |
Apr 12, 2023 |
Apr 12, 2023 |
None
|
| 2885 |
2133: Increase, Glucuronidation of T4 |
961: Increased, Clearance of thyroxine from serum |
Apr 12, 2023 |
Apr 12, 2023 |
None
|
| 2888 |
18: Activation, AhR |
345: N/A, Liver Steatosis |
Apr 13, 2023 |
Apr 13, 2023 |
None
|
| 2889 |
345: N/A, Liver Steatosis |
55: Cell injury/death |
Apr 13, 2023 |
Apr 13, 2023 |
None
|
| 2890 |
55: Cell injury/death |
1494: Leukocyte recruitment/activation |
Apr 13, 2023 |
Apr 13, 2023 |
None
|
| 2891 |
1494: Leukocyte recruitment/activation |
1501: Increase, ECM deposition |
Apr 13, 2023 |
Apr 13, 2023 |
None
|
| 2873 |
2123: decreased, Bcl-2 |
1825: Increase, Cell death |
Apr 4, 2023 |
Apr 4, 2023 |
None
|
| 2926 |
25: Agonism, Androgen receptor |
2139: Reduction, the ratio of E2/11-KT in plasma |
May 22, 2023 |
May 22, 2023 |
None
|
| 2927 |
1702: Suppression of T cell activation |
1700: Impaired IL-1R1 signaling |
May 24, 2023 |
May 24, 2023 |
None
|
| 2931 |
179: Decrease, Fatty acid β-oxidation |
1816: Mitochondrial dysfunction EMPTY |
May 25, 2023 |
May 25, 2023 |
None
|
| 2932 |
1816: Mitochondrial dysfunction EMPTY |
2144: Impaired insulin signaling |
May 25, 2023 |
May 25, 2023 |
None
|
| 2576 |
1196: Increased, Invasion |
1193: N/A, Breast Cancer |
Feb 15, 2022 |
Feb 15, 2022 |
None
|
| 2578 |
1376: Increase, angiogenesis |
1193: N/A, Breast Cancer |
Feb 15, 2022 |
Feb 15, 2022 |
None
|
| 2579 |
1971: tumor growth |
1193: N/A, Breast Cancer |
Feb 15, 2022 |
Feb 15, 2022 |
None
|